Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Galangin
Cat. No.:
OB0225LY-0484
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Galangin is a plant-derived flavonoid with antioxidant, anti-inflammatory and anti-tumor properties.
Synonym:
Norizalpinin; 3,5,7-Trihydroxyflavone; 548-83-4; 3,5,7-Trihydroxy-2-phenyl-4H-chromen-4-one; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-phenyl-; 3,5,7-Trihydroxy-2-phenyl-4-benzopyrone; 3,5,7-Trihydroxy-2-phenylchromen-4-one
CAS No.:
548-83-4
Compound CID:
5281616
Formula:
C15H10O5
Formula Weight:
270.24
Specification
Relative Density:
1.579 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Galangin can be used to study the mechanism of apoptosis in cancer cells.
Library Information
Targets:
Kinases/Transcription factors; Cytochrome P450 enzymes
Receptors:
Cytochrome P450; ERK; NF-κB; CYP1A1
Pathways:
Autophagy; NF-κB; MAPK; Metabolism
Plate Number:
AOCL-7
Plate Location:
c4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
60 mg/mL; 222.06 mM
Solubility:
Soluble in chloroform, dichloromethane, ethyl acetate, and acetone.
ALogP:
2.114
HBA_Count:
2
HBD_Count:
3
Rotatable Bond:
1
